CELC: the balance sheet

MyFinsight

For the year ending 2025-12-31, CELC has $466,558K in assets. $366,003K in debts. $165,703K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	165,703
Investments	275,794
Prepaid clinical trial costs	18,896
Other current assets	5,266
Total current assets	465,659
Total property and equipment, gross	2,658
Less accumulated depreciation	2,159
Property and equipment, net	499
Operating lease right-of-use assets	51
Other non-current assets	349
Total assets	466,558

Accounts payable	6,407
Accrued clinical trial costs	16,826
Other accrued expenses	20,865
Operating lease liabilities, current	54
Total current liabilities	44,152
Convertible debt	195,324
Note payable, non-current	126,527
Total liabilities	366,003
Common stock, 0.001 par value 95,000,000 shares authorized as of december 31, 2025 and 2024 48,244,960 and 37,143,242 shares issued and outstanding as of december 31, 2025 and 2024, respectively	48
Additional paid-in capital	549,404
Accumulated deficit	-448,897
Total stockholders equity	100,555
Total liabilities and stockholders equity	466,558

Unit: Thousand (K) dollars (except for numbers of shares and EPS).